找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Application of Nanocarriers in Brain Delivery of Therapeutics; Amit Alexander Book 2024 The Editor(s) (if applicable) and The Author(s), u

[復(fù)制鏈接]
樓主: JOLT
41#
發(fā)表于 2025-3-28 15:49:48 | 只看該作者
42#
發(fā)表于 2025-3-28 22:18:43 | 只看該作者
In Vitro Cell Line Culture for Brain Research and Its Limitations,cell line models for brain research. These models encompass a wide array of neuronal and glial cell lines, primary cultures, and sophisticated systems that closely mimic the brain’s intricate microenvironments. They have become invaluable tools for investigating various facets of brain biology and p
43#
發(fā)表于 2025-3-29 00:22:03 | 只看該作者
44#
發(fā)表于 2025-3-29 06:57:11 | 只看該作者
Safety, Stability Concerns, and Regulatory Aspects of Nanocarriers for Brain Delivery,he nanocarriers derived from metals, polymers, and other materials have shown their therapeutic efficacy against several neurological disorders during in vitro and preclinical studies. However, these nanocarriers, especially metal and silica NPs, have shown their toxicity against neuronal cell lines
45#
發(fā)表于 2025-3-29 10:42:33 | 只看該作者
Current Clinical Advancements of Nanocarriers for Brain Targeting and Limitations in Clinical Trans drug targeting, minimized side effects, improved drug efficiency, and patient compliance, nanocarriers take upper hand. Successful translation of research hypothesis led to clinical availability of a good number of nanomedicines intended for a range of physiological conditions like kidney dysfuncti
46#
發(fā)表于 2025-3-29 14:51:48 | 只看該作者
Application of Nanocarriers in Brain Delivery of Therapeutics
47#
發(fā)表于 2025-3-29 17:04:33 | 只看該作者
Application of Nanocarriers in Brain Delivery of Therapeutics978-981-97-2859-6
48#
發(fā)表于 2025-3-29 23:45:44 | 只看該作者
49#
發(fā)表于 2025-3-30 00:11:25 | 只看該作者
50#
發(fā)表于 2025-3-30 07:21:13 | 只看該作者
https://doi.org/10.1007/978-94-015-8175-2n disorders. However, bioactives have low bioavailability, poor solubility, and inefficient delivery because of blood-central nervous system barriers. To overcome these issues, a lipid nanocarrier system was found to be a suitable strategy for delivering these bioactives. This chapter discusses lipo
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 11:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
白水县| 武胜县| 青田县| 巍山| 四会市| 文水县| 甘肃省| 广南县| 勐海县| 安顺市| 蕲春县| 五常市| 辽源市| 滦南县| 区。| 郯城县| 唐河县| 五寨县| 邯郸县| 昭觉县| 西昌市| 常山县| 江源县| 九龙城区| 关岭| 陆川县| 黑山县| 西宁市| 揭阳市| 辛集市| 阳春市| 海淀区| 嘉禾县| 道真| 电白县| 尼玛县| 宕昌县| 盐城市| 林周县| 宣威市| 怀仁县|